Reading TXMD? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track TXMD free→Reading TXMD? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track TXMD free→QuarterlyIQ Insights · TXMD
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Results of Operations and Financial Condition. The information provided in
Results of Operations and Financial Condition. The information provided in
Changes in Registrant’s Certifying Accountant. On January 15, 2026, the Audit Committee of the Board of Directors of TherapeuticsMD, Inc., a Nevada corporation (the “Company”), approved the appointment of Carr, Riggs & Ingram, L.L.C. (“CRI”) as the Company’s independent registered public accounting firm, effective immediately. In connection therewith, Berkowitz Pollack Brant Advisors + CPAs (“BPB”), the Company’s prior independent registered public accounting firm, ceased serving as the Compa…
Results of Operations and Financial Condition. The information provided in
Results of Operations and Financial Condition. The information provided in
Results of Operations and Financial Condition. The information provided in
Other Events. On April 8, 2025, TherapeuticsMD, Inc., a Nevada corporation (the “Company”), filed a lawsuit against Mayne Pharma LLC (“Mayne Pharma”) in the United States District Court for the District of Delaware (the “Mayne Lawsuit”) seeking damages for breach of contract, breach of the implied covenant of good faith and fair dealing, fraudulent inducement, and unjust enrichment related to Mayne Pharma’s actions in relation to the License Agreement, dated December 4, 2022, as amended, betw…
Results of Operations and Financial Condition. The information provided in
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.